US HB7971 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on August 7 2020 - 25% progression, died in committee
Action: 2020-08-07 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on August 7 2020 - 25% progression, died in committee
Action: 2020-08-07 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To direct the Food and Drug Administration to solicit and consider the recommendations of the Vaccines and Related Biological Products Advisory Committee before taking certain actions with respect to COVID-19 vaccines, and for other purposes.
Title
EVALUATE Act Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act
Sponsors
| Rep. Raja Krishnamoorthi [D-IL] | Rep. Gerald Connolly [D-VA] | Rep. Rashida Tlaib [D-MI] | Rep. Ayanna Pressley [D-MA] |
| Rep. Katie Porter [D-CA] | Rep. Ro Khanna [D-CA] | Rep. Mark DeSaulnier [D-CA] | Rep. Seth Moulton [D-MA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-08-07 | House | Referred to the House Committee on Energy and Commerce. |
| 2020-08-07 | House | Introduced in House |
Subjects
Advisory bodies
Cardiovascular and respiratory health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Food and Drug Administration (FDA)
Government information and archives
Health
Immunology and vaccination
Infectious and parasitic diseases
Licensing and registrations
Medical research
Public participation and lobbying
Cardiovascular and respiratory health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Food and Drug Administration (FDA)
Government information and archives
Health
Immunology and vaccination
Infectious and parasitic diseases
Licensing and registrations
Medical research
Public participation and lobbying
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/7971/all-info |
| Text | https://www.congress.gov/116/bills/hr7971/BILLS-116hr7971ih.pdf |
